• Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Uroplasty Inc

+ Add to Watchlist


1.134 EUR 0.300 20.92%

As of 13:44:12 ET on 01/23/2015.

Snapshot for Uroplasty Inc (URN)

Open: 1.387 Day's Range: 1.134 - 1.398 Volume: 0
Previous Close: 1.434 52wk Range: 1.134 - 3.457 1-Yr Rtn: -65.17%

Stock Chart for URN

No chart data available.
  • URN:GR 1.134
  • 1D
  • 1M
  • 1Y
Interactive URN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for URN

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (03/2015) -0.2520
Est. PEG Ratio -
Market Cap (M EUR) 25.11
Shares Outstanding (M) 22.15
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for URN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for URN

Uroplasty, Inc. designs, develops, manufactures, and markets medical products primarily for the treatment of voiding dysfunctions. The Company's principal product is Urgent PC Neuromodulation System which is a system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder. Uroplasty also offers Macroplastique, a bulking agent.

Kill C Robert "Rob"President/CEOBrett A ReynoldsSenior VP/CFO/Secretary
Darin HammersSenior VP:Global Sales & MktgDavid B PerryVP:Marketing
More Company Profile & Key Executives for URN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil